Put Options

15 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$772.14 - $960.02 $463,284 - $576,012
-600 Reduced 42.86%
800 $708,000
Q2 2024

Aug 05, 2024

BUY
$724.87 - $909.04 $1.01 Million - $1.27 Million
1,400 New
1,400 $1.27 Million
Q3 2023

Nov 03, 2023

BUY
$434.7 - $599.3 $1.04 Million - $1.44 Million
2,400 New
2,400 $1.29 Million
Q1 2023

May 10, 2023

SELL
$310.63 - $364.82 $3.6 Million - $4.23 Million
-11,600 Reduced 13.11%
76,900 $26.4 Million
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $23.7 Million - $27.7 Million
73,800 Added 502.04%
88,500 $32.4 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $5.07 Million - $5.78 Million
-17,100 Reduced 53.77%
14,700 $4.75 Million
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $8.86 Million - $10.4 Million
31,800 New
31,800 $10.3 Million
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $2.05 Million - $2.54 Million
-9,100 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $2.02 Million - $2.48 Million
9,100 New
9,100 $2.1 Million
Q1 2021

May 14, 2021

SELL
$164.32 - $212.72 $3.38 Million - $4.38 Million
-20,600 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $2.69 Million - $3.56 Million
20,600 New
20,600 $3.48 Million
Q2 2020

Aug 14, 2020

SELL
$136.42 - $164.18 $9.56 Million - $11.5 Million
-70,100 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$119.05 - $147.35 $130,955 - $162,085
-1,100 Reduced 1.54%
70,100 $9.72 Million
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $6.01 Million - $7.44 Million
56,200 Added 374.67%
71,200 $9.36 Million
Q3 2019

Nov 14, 2019

BUY
$106.79 - $116.16 $1.6 Million - $1.74 Million
15,000 New
15,000 $1.68 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $770B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Capula Management LTD Portfolio

Follow Capula Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Capula Management LTD with notifications on news.